Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 39 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $17,516,000 | +2392796.2% | 1,450,000 | +866.7% | 1.01% | +1965.3% |
Q4 2022 | $732 | -100.0% | 150,000 | 0.0% | 0.05% | -67.5% |
Q3 2022 | $2,163,000 | -4.7% | 150,000 | 0.0% | 0.15% | -12.2% |
Q2 2022 | $2,270,000 | +27.4% | 150,000 | 0.0% | 0.17% | +25.5% |
Q1 2022 | $1,782,000 | -63.4% | 150,000 | -50.0% | 0.14% | -52.6% |
Q4 2021 | $4,863,000 | -65.9% | 300,000 | -40.0% | 0.29% | -50.2% |
Q3 2021 | $14,270,000 | -47.2% | 500,000 | -37.5% | 0.58% | -36.9% |
Q2 2021 | $27,040,000 | -27.3% | 800,000 | -35.0% | 0.92% | +10.9% |
Q1 2021 | $37,195,000 | -54.8% | 1,230,000 | -26.0% | 0.83% | -57.7% |
Q4 2020 | $82,268,000 | +53.3% | 1,661,647 | +18.9% | 1.96% | -5.1% |
Q3 2020 | $53,658,000 | -21.1% | 1,397,700 | -11.2% | 2.06% | -20.5% |
Q2 2020 | $68,026,000 | +50.5% | 1,574,683 | -9.1% | 2.60% | +23.6% |
Q1 2020 | $45,210,000 | -9.7% | 1,732,200 | +8.1% | 2.10% | +5.2% |
Q4 2019 | $50,074,000 | +117.4% | 1,602,376 | +81.3% | 2.00% | +42.5% |
Q3 2019 | $23,032,000 | +0.7% | 883,800 | -11.6% | 1.40% | +6.7% |
Q2 2019 | $22,870,000 | +22.0% | 1,000,000 | +39.8% | 1.31% | +3.7% |
Q1 2019 | $18,753,000 | +373.4% | 715,482 | +267.4% | 1.27% | +293.5% |
Q4 2018 | $3,961,000 | -25.4% | 194,768 | -2.6% | 0.32% | -6.7% |
Q3 2018 | $5,312,000 | – | 200,000 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,757,000 | 9.37% |
Sofinnova Investments, Inc. | 2,194,278 | $31,641,000 | 1.84% |
MPM BioImpact LLC | 443,702 | $6,398,000 | 1.52% |
Artal Group S.A. | 400,000 | $5,768,000 | 0.25% |
Polar Capital Holdings Plc | 2,531,546 | $36,505,000 | 0.23% |
ASHFORD CAPITAL MANAGEMENT INC | 101,970 | $1,470,000 | 0.22% |
Lombard Odier Asset Management (Switzerland) SA | 168,795 | $2,434,000 | 0.21% |
Soleus Capital Management, L.P. | 87,182 | $1,257,000 | 0.17% |
Cormorant Asset Management, LP | 150,000 | $2,163,000 | 0.15% |
Walleye Capital LLC | 437,344 | $6,307,000 | 0.12% |